Buprenorphine
- Level
- Commodity
- Parent
- 51372000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51372003This classification denotes an opioid receptor agonist and opioid with the molecular formula C29H41NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40D3SCR4GZ, chemically known as 6,14-ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5-alpha,7-alpha-(s))- but generally known as buprenorphine, which bears US NIH Compound Identifier 40400. Buprenorphine most often comes in base and hydrochloride forms. European Medicines Agency schedules Buprenorphine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05985MIG. The term BUPRENORPHINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules buprenorphine in its Anatomical Therapeutic Chemical (ATC) Classification. BUPRENORPHINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule buprenorphine under HS 29391100 and SITC 54141. As of Q4 2014, BUPRENORPHINE remains the US FDA Preferred Term for this commodity. Buprenorphine bears US NLM identifiers UMLS ID C0006405 and NCI Concept Code C61656. SMILES: O1C2C34C5(CC(C2(OC)CC5)C(O)(C(C)(C)C)C)C(N(CC3)CC2CC2)CC2C4C1C(O)CC2.
Same parent
Under 51372000 · 42Activities that produce or sell this
KBLI · 8Inherited from family 51370000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.